The role of mTOR inhibitors in the prevention of organ rejection in adult liver transplant patients: a focus on everolimus
Teresa Casanovas Liver Transplant Unit, Bellvitge University Hospital, Barcelona, Spain Abstract: Liver transplantation remains the therapy of choice for patients with end-stage liver disease and in selected cases of hepatocellular carcinoma. While short-term allograft survival has improved signif...
Main Author: | Casanovas T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-06-01
|
Series: | Transplant Research and Risk Management |
Online Access: | http://www.dovepress.com/the-role-of-mtor-inhibitors-in-the-prevention-of-organ-rejection-in-ad-a17345 |
Similar Items
-
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
by: Yim K-L
Published: (2012-07-01) -
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
by: Goran B. Klintmalm, et al.
Published: (2014-01-01) -
A Decade of Experience Using mTor Inhibitors in Liver Transplantation
by: Jeffrey Campsen, et al.
Published: (2011-01-01) -
Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.
by: Michael K Kiessling, et al.
Published: (2016-01-01) -
Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells
by: Saira Justin, et al.
Published: (2020-06-01)